Workboat Indexes
Lantern Pharma Inc (NQ: LTRN )
4.440
+0.040
(+0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
All News about Lantern Pharma Inc
![](https://mms.businesswire.com/media/20230315005265/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230313005150/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230313005283/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230309005311/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230308005141/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230306005304/en/1730272/22/Starlight_Therapeutics_Pipeline.jpg)
![](https://mms.businesswire.com/media/20230302005267/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230227005262/en/1718670/5/Lantern_Logo_Stacked.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/ai1600.jpg)
![](https://mms.businesswire.com/media/20230215005278/en/1714101/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230117005407/en/1687176/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20230105005372/en/1677714/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20221215005355/en/1666023/22/Lantern_Pharma_ASH_Poster_Results_2.jpg)
![](https://mms.businesswire.com/media/20221213005431/en/1662969/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20221122005225/en/1644652/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20221107005752/en/1627594/5/Lantern_Logo_Stacked.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5934.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221102005296/en/1621844/5/Lantern_Logo_Stacked.jpg)
From Lantern Pharma Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20221031005162/en/1618249/5/Lantern_Logo_Stacked.jpg)
![](https://mms.businesswire.com/media/20221025005214/en/1611996/5/Lantern_Logo_Stacked.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6692.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20213.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_20091.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20221019005401/en/1606765/5/Lantern_Logo_Stacked.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_18941.jpeg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://mms.businesswire.com/media/20221005005194/en/1592256/5/Lantern_Logo_Stacked.jpg)
Lantern Pharma to Present at Upcoming Investor Conferences
October 05, 2022
From Lantern Pharma Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.